Figure 3. miRNA expression in patients with progressive disease (group 1) compared with patients with clinical benefit (stable disease + partial response + complete response; group 2). Statistically significant miR expression levels of (A) miR-200b, (B) miR-34a, (C) miR-21, (D) miR-200a and (E) miR-193b. miR, microRNA.
Fuente:
Zenodo
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2024
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|